Skip to content

Effect of nasal drops(nasya) and massage (abhyanga) for the treatment of cervical spondylosis (neck pain)

Efficacy of Nasya and Nasya With Abhyanga With Nirgundi Taila in the Management of Cervical Spondylosis (Manyastambha)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035748
Enrollment
40
Registered
2021-08-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M470- Anterior spinal and vertebral artery compression syndromes Health Condition 2: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

None listed

Sponsors

Dr Sai Trilochan Pappu
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either genders and age between 30 to 70 years. Patients fit for Nasya karma Patients presenting signs and symptoms of cervical spondylosis. Patients who are pre diagnosed with cervical spondylosis.

Exclusion criteria

Exclusion criteria: Patients with injury to cervical spine. Patients with systemic disorders that might interfere with the treatment procedure like Hypertension, Diabetes Mellitus, and known case of Thyroid dysfunction. Patients that are known case of neoplastic conditions. Patients with cervical myelopathy. Pregnant and lactating women. Those people who fall on either side of the age group taken into consideration are excluded.

Design outcomes

Primary

MeasureTime frame
Reduction of - 1. Pain in the neck using Neck Disability Index. 2. Stiffness in the neck region Improvement in Range of motion Timepoint: assessment will be done in 3 weeks

Secondary

MeasureTime frame
Samyak Nasya lakshana observedTimepoint: Will be assessed during the course of the therapy for seven days

Countries

India

Contacts

Public ContactDr Sai Trilochan Pappu

Sri Jayendra Saraswathi Ayurveda College and Hospital

drug77ayu@sjsach.org.in9043214345

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026